ONE-TWENTY TWO: Trading Financial Markets
Exploring the poetry in financial markets for students of money and economy since the year 2000.
(This is an excerpt from an article I originally published on Seeking Alpha on October 19, 2016. Click here to read the entire piece.) Mylan (MYL) is down 13% (and as much as 17%) since I argued the company was “out of tune” with an angry chorus that promised to place a lot of short-term … Read more
Drug corporations' greed is unbelievable. Ariad has raised the price of a leukemia drug to almost $199,000 a year. https://t.co/EB4nEPxP2G — Bernie Sanders (@SenSanders) October 14, 2016 The drug industry is getting very, very nervous. We are going to take them on and lower the cost of medication across this country. https://t.co/6PeiLJnR0F — Bernie Sanders … Read more
Gold and silver may have finally topped out. The first technical clues came after SPDR Gold Shares (GLD) reversed all its incremental gains form the post-Brexit trade. I used that event and other indicators to posit a top for gold in late July. GLD promptly bounced from that support level. A month later I reiterated … Read more
(This is an excerpt from an article I originally published on Seeking Alpha on September 25, 2016. Click here to read the entire piece.) Source: UK Government Nothing shows better the edginess of traders than a quick trigger reaction to rumored news. On Friday, September 16 rumors ripped through the news headlines that the UK’s … Read more
(This is an excerpt from an article I originally published on Seeking Alpha on August 29, 2016. Click here to read the entire piece.) This is the message actress Sarah Jessica Parker posted on Instagram Thursday, August 25, 2016 to join a chorus of protest and complaint about the extremely high cost of the EpiPen® … Read more